Evidence map›Paper›PMID 27862610›Full record

ArticleJournal of mass spectrometry : JMS2017

Effects of covalent modification by 4-hydroxy-2-nonenal on the noncovalent oligomerization of ubiquitin.

Giuseppe Grasso, Paul H Axelsen

Abstract read
In one paragraph

Article in Journal of mass spectrometry : JMS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Giuseppe GrassoUniversity of Catania, Viale A. Doria 6, 95125, Catania, Italy.
Paul H AxelsenDepartment of Pharmacology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
University of Catania · ITUniversity of Pennsylvania · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca A Simmons · 2006 to 2026
$35.3M
Structure determination by vibrational spectroscopyR01GM076201 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI AXELSEN, PAUL H · 2007 to 2018
$3.2M
Oxidative lipid stress in the brainR01NS074178 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI AXELSEN, PAUL H · 2011 to 2015
$1.7M
Membrane Mediated AmyloidogenesisR01AG020238 · NIA · UNIVERSITY OF PENNSYLVANIA · PI AXELSEN, PAUL H. · 2002 to 2006
$1.5M
NIA NIH HHS R01 AG020238NIEHS NIH HHS P30 ES013508NIGMS NIH HHS R01 GM076201NINDS NIH HHS R01 NS074178
6 · The paper itself

Abstract

When lipid membranes containing ω-6 polyunsaturated fatty acyl chains are subjected to oxidative stress, one of the reaction products is 4-hydroxy-2-nonenal (HNE)-a chemically reactive short chain alkenal that can covalently modify proteins. The ubiquitin proteasome system is involved in the clearing of proteins modified by oxidation products such as HNE, but the chemical structure, stability and function of ubiquitin may be impaired by HNE modification. To evaluate this possibility, the susceptibility of ubiquitin to modification by HNE has been characterized over a range of concentrations where ubiquitin forms non-covalent oligomers. Results indicate that HNE modifies ubiquitin at only two of the many possible sites, and that HNE modification at these two sites alters the ubiquitin oligomerization equilibrium. These results suggest that any role ubiquitin may have in clearing proteins damaged by oxidative stress may itself be impaired by oxidative lipid degradation products. Copyright © 2016 John Wiley & Sons, Ltd.

Indexed as

AldehydesChromatography, High Pressure LiquidKineticsPolymerizationProtein FoldingTandem Mass SpectrometryUbiquitin4-hydroxy-2-nonenalAldehydesUbiquitin4-hydroxy-2-nonenalAlzheimer's diseaseoxidative stressphotocrosslinkingtandem mass spectrometryubiquitin

Identifiers

PMID27862610
PMCPMC5360464
OpenAlexW2556545887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.